Boxer Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,960,910
Closed -$17.4M 16
2024
Q3
$17.4M Sell
4,960,910
-3,255,000
-40% -$12.7M 0.85% 33
2024
Q2
$26.9M Hold
8,215,910
1.42% 20
2024
Q1
$60.3M Buy
8,215,910
+7,715,910
+1,543% +$47.8M 2.98% 13
2023
Q4
$1.87M Hold
500,000
0.09% 42
2023
Q3
$1.06M Hold
500,000
0.06% 63
2023
Q2
$2.38M Hold
500,000
0.11% 64
2023
Q1
$2.85M Sell
500,000
-750,000
-60% -$4.53M 0.14% 60
2022
Q4
$12.6M Buy
1,250,000
+900,000
+257% +$16.9M 0.66% 40
2022
Q3
$7.84M Sell
350,000
-150,000
-30% -$4.33M 0.44% 43
2022
Q2
$12.4M Hold
500,000
0.78% 41
2022
Q1
$19.4M Hold
500,000
1% 32
2021
Q4
$29.3M Buy
+500,000
New +$28.3M 1.16% 23

Other funds holding FATE